92 related articles for article (PubMed ID: 2902212)
1. Phorbol ester-induced modulation of agonist binding to alpha-1 adrenergic receptors in bovine aortic membranes.
Jagadeesh G; Deth RC
J Pharmacol Exp Ther; 1988 Oct; 247(1):196-202. PubMed ID: 2902212
[TBL] [Abstract][Full Text] [Related]
2. Phorbol ester and staurosporine modulation of antagonist and agonist binding to alpha-2 adrenergic receptors: differential influence on Na+ versus guanylylnucleotide regulation.
Jagadeesh G; Deth RC
J Pharmacol Exp Ther; 1992 Aug; 262(2):775-83. PubMed ID: 1323662
[TBL] [Abstract][Full Text] [Related]
3. Agonist-induced modulation of agonist binding to alpha 1-adrenoceptors in bovine aorta.
Jagadeesh G; Tian WN; Deth RC
Eur J Pharmacol; 1991 Oct; 208(2):163-70. PubMed ID: 1686866
[TBL] [Abstract][Full Text] [Related]
4. Different affinity states of alpha-1 adrenergic receptors defined by agonists and antagonists in bovine aorta plasma membranes.
Jagadeesh G; Deth RC
J Pharmacol Exp Ther; 1987 Nov; 243(2):430-6. PubMed ID: 2890755
[TBL] [Abstract][Full Text] [Related]
5. Agonist and antagonist binding to alpha 2-adrenergic receptors in purified membranes from human platelets. Implications of receptor-inhibitory nucleotide-binding protein stoichiometry.
Neubig RR; Gantzos RD; Brasier RS
Mol Pharmacol; 1985 Nov; 28(5):475-86. PubMed ID: 2865672
[TBL] [Abstract][Full Text] [Related]
6. Alpha 1-adrenergic receptor-linked guanine nucleotide-binding protein in muscle and kidney epithelial cells.
Terman BI; Slivka SR; Hughes RJ; Insel PA
Mol Pharmacol; 1987 Jan; 31(1):12-20. PubMed ID: 3027523
[TBL] [Abstract][Full Text] [Related]
7. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
Paris H; Galitzky J; Senard JM
Mol Pharmacol; 1989 Mar; 35(3):345-54. PubMed ID: 2564632
[TBL] [Abstract][Full Text] [Related]
8. Effect of islet-activating pertussis toxin on the binding characteristics of Ca2+-mobilizing hormones and on agonist activation of phosphorylase in hepatocytes.
Lynch CJ; Prpic V; Blackmore PF; Exton JH
Mol Pharmacol; 1986 Feb; 29(2):196-203. PubMed ID: 3005828
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of adenylate cyclase is mediated by the high affinity conformation of the alpha 2-adrenergic receptor.
Thomsen WJ; Jacquez JA; Neubig RR
Mol Pharmacol; 1988 Dec; 34(6):814-22. PubMed ID: 2904647
[TBL] [Abstract][Full Text] [Related]
10. Role of phorbol ester receptors in the 12-0-tetradecanoyl-phorbol-13-acetate (TPA)-induced down-regulation of colony-stimulating factor (CSF-1) binding to murine peritoneal exudate macrophages.
Chen BD; Wilkins KL
J Cell Physiol; 1985 Aug; 124(2):305-12. PubMed ID: 3876342
[TBL] [Abstract][Full Text] [Related]
11. Compartmentation of alpha 2-adrenergic receptors in human erythroleukemia (HEL) cells.
McKernan RM; Howard MJ; Motulsky HJ; Insel PA
Mol Pharmacol; 1987 Aug; 32(1):258-65. PubMed ID: 3039340
[TBL] [Abstract][Full Text] [Related]
12. Evidence for agonist-induced interaction of angiotensin receptor with a guanine nucleotide-binding protein in bovine adrenal zona glomerulosa.
De Léan A; Ong H; Gutkowska J; Schiller PW; McNicoll N
Mol Pharmacol; 1984 Nov; 26(3):498-508. PubMed ID: 6092899
[TBL] [Abstract][Full Text] [Related]
13. Regulation of [3H]phorbol-12,13-dibutyrate binding sites in mouse neuroblastoma cells: simultaneous down-regulation by phorbol esters and desensitization of their inhibition of muscarinic receptor function.
Lai WS; el-Fakahany EE
J Pharmacol Exp Ther; 1988 Jan; 244(1):41-50. PubMed ID: 3422096
[TBL] [Abstract][Full Text] [Related]
14. Evidence for alpha 1-adrenergic receptor internalization in DDT1 MF-2 cells following exposure to agonists plus protein kinase C activators.
Cowlen MS; Toews ML
Mol Pharmacol; 1988 Sep; 34(3):340-6. PubMed ID: 2901664
[TBL] [Abstract][Full Text] [Related]
15. Tight agonist binding may prevent the correct interpretation of agonist competition binding curves for alpha 2-adrenergic receptors.
Convents A; De Backer JP; Convents D; Vauquelin G
Mol Pharmacol; 1987 Jul; 32(1):65-72. PubMed ID: 2885739
[TBL] [Abstract][Full Text] [Related]
16. Developmental changes of the alpha-1-adrenergic receptor system in rat liver.
Lange R; Hermsdorf T; Dettmer D; Hofmann E
Biomed Biochim Acta; 1987; 46(11):781-9. PubMed ID: 2833251
[TBL] [Abstract][Full Text] [Related]
17. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
Graeser D; Neubig RR
Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695
[TBL] [Abstract][Full Text] [Related]
18. Estradiol reduction of the agonist high affinity form of the alpha 2-adrenoceptor in the hypothalamus of female rats: identification as the alpha 2D subtype.
Karkanias GB; Etgen AM
Mol Pharmacol; 1994 Mar; 45(3):509-16. PubMed ID: 7908407
[TBL] [Abstract][Full Text] [Related]
19. Effects of agonist and phorbol ester on adrenergic receptors of DDT1 MF-2 cells.
Cowlen MS; Toews ML
J Pharmacol Exp Ther; 1987 Nov; 243(2):527-33. PubMed ID: 2824749
[TBL] [Abstract][Full Text] [Related]
20. Human fat cell alpha-2 adrenoceptors. II. Comparative study of partial and full agonist binding parameters using [3H]clonidine and [3H]UK-14,304.
Galitzky J; Lafontan M; Paris H; Berlan M
J Pharmacol Exp Ther; 1989 May; 249(2):592-600. PubMed ID: 2566682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
